31/05/2024  17:56:10 Diferencia -0.780 Volumen Bid22:00:01 Ask22:00:01 Capitalización de mecado Dividendo A. P/E Ratio
99.520EUR -0.78% 0
Volumen de negocios: 0.000
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 12.43 mil millonesEUR - -

Descripción de negocio

Revvity offers products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
 

Consejo de gestión & Consejo de supervisión

CEO
Dr. Prahlad Singh
Consejo de gestión
Max Krakowiak, Yves Dubaquie, Alan Fletcher, Magali Four, Joel Goldberg, Madhuri Hegde, Yi-Ping Lin, Dan Tereau, Jayashree Thacker, Miriame Victor, Tajinder Vohra, Kevin Willoe, Arvind Sundar-Rajan
Consejo de supervisión
Alexis P. Michas, Peter Barrett, Samuel R. Chapin, Dr. Sylvie Grégoire, Dr. Michelle McMurry-Heath, Dr. Prahlad Singh, Michel Vounatsos, Frank Witney, Pascale Witz
 

Datos de la empresa

Nombre: Revvity
Dirección: 940 Winter Street,Waltham, Massachusetts 02451, USA
Teléfono: +1-781-663-6900
Fax: -
E-mail: -
Internet: https://www.revvity.com
Industria: Healthcare
Sector: Healthcare Providers
Subsector: Healthcare Providers
Fin del año financiero: 31/12
Acciones de libre circulación: 60.70%
Fecha de OPI: 13/12/1960

Relación con inversores

Nombre: Steve Willoughby
IR teléfono: +1-781-663-5677
IR-fax: -
IR e-mail: ir@revvity.com